Skip to main content
. Author manuscript; available in PMC: 2013 Jul 22.
Published in final edited form as: Curr HIV/AIDS Rep. 2012 Jun;9(2):101–110. doi: 10.1007/s11904-012-0113-0

Table 2.

Rationale for and against starting ART during acute HIV

Rationale for ART in acute HIV

  • To reduce the risk of viral transmission

  • To decrease viral reservoir for future therapeutic vaccines or immunotherapies

  • As earlier ART is indicated, why wait?

Disadvantages of ART in acute HIV

  • Potential development of drug resistance if patient is non-adherent

  • Earlier commitment to lifelong therapy

  • Less time to educate patient about ART

  • Insufficient data regarding effectiveness of early treatment